Faecal calprotectin is highly effective to detect endoscopic ulcerations in Crohn's disease regardless of disease location

被引：0
|
作者：
Buisson, A. [1 ,2 ,3 ]
Mak, W. Y. [4 ,5 ]
Andersen, M. J., Jr. [5 ]
Lei, D. [5 ]
Pekow, J. [5 ]
Cohen, R. D. [5 ]
Pereira, B. [6 ]
Rubin, D. T. [5 ]
机构：
[1] Univ Hosp Estaing, Gastroenterol Dept, Clermont Ferrand, France
[2] Univ Auvergne, INSERM, UMR 1071, Clermont Ferrand, France
[3] USC INRA 2018, Microbes Intestine Inflammat & Susceptibil Host, Clermont Ferrand, France
[4] Queen Elizabeth Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[5] Univ Chicago Med, Inflammatory Bowel Dis Ctr, Chicago, IL USA
[6] Univ Hosp, Biostat Unit, DRCI, Clermont Ferrand, France
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P306
引用
收藏
页码：S255 / S255
页数：1
相关论文
共 50 条
  • [41] Endoscopic Factors Influencing Fecal Calprotectin Value in Crohn's Disease
    Goutorbe, F.
    Goutte, M.
    Minet-Quinard, R.
    Boucher, A-L.
    Pereira, B.
    Bommelaer, G.
    Buisson, A.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 (12): : 1113 - 1119
  • [42] Faecal Calprotectin and Ileal Crohn's Disease: Correlation With a Small Bowel MRI Score for Disease Activity
    Fasci-Spurio, Federica
    Kennedy, Nicholas A.
    Wong, Li
    MacLean, Peter
    Satsangi, Jack
    Glancy, Stephen
    Lees, Charlie W.
    GASTROENTEROLOGY, 2014, 146 (05) : S231 - S232
  • [43] Faecal calprotectin and ileal Crohn's disease: correlation with a small bowel MRI score for disease activity
    Fasci-Spurio, F.
    Kennedy, N. A.
    Wong, L.
    MacLean, P.
    Satsangi, J.
    Glancy, S.
    Lees, C. W.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S154 - S154
  • [44] The Utility of Faecal Calprotectin, Lactoferrin and Other Faecal Biomarkers in Discriminating Endoscopic Activity in Crohn's Disease: A Systematic Review and Meta-Analysis
    Bohra, Anuj
    Mohamed, Ghada
    Vasudevan, Abhinav
    Lewis, Diana
    Van Langenberg, Daniel R. R.
    Segal, Jonathan P. P.
    BIOMEDICINES, 2023, 11 (05)
  • [45] FAECAL CALPROTECTIN AND ILEAL CROHN'S DISEASE: CORRELATION WITH A SMALL BOWEL MRI SCORE FOR DISEASE ACTIVITY
    Fasci-Spurio, F.
    Kennedy, N. A.
    Wong, L.
    MacLean, P.
    Satsangi, J.
    Glancy, S.
    Lees, C. W.
    GUT, 2014, 63 : A74 - A75
  • [46] Fecal calprotectin is an effective marker of disease activity in patients with ileal Crohn's disease
    Picardo, S.
    So, K.
    Venugopal, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 140 - 141
  • [47] Chronic cheilitis: Faecal calprotectin test a way to diagnose oral Crohn's disease
    Harris, Victoria
    Smith, Saxon D.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2017, 58 (04) : 324 - 325
  • [48] Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study
    Deshpande, A. R.
    Strobel, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (05) : 586 - 586
  • [49] RAISED FAECAL CALPROTECTIN FOLLOWING RESECTION FOR CROHN'S DISEASE IS ASSOCIATED WITH POSTOPERATIVE RECURRENCE
    Brownson, Emily
    Nicholson, Gary
    Macdonald, Jonathan
    Seenan, John Paul
    GUT, 2022, 71 : A39 - A39
  • [50] AUDIT AT ONE YEAR OF GUIDELINES FOR THE USE OF FAECAL CALPROTECTIN IN MONITORING CROHN'S DISEASE
    Turvill, J.
    Maxine, R.
    Rook, L.
    Robins, G.
    Kant, P.
    Smale, S.
    GUT, 2015, 64 : A231 - A232
12345